Vulnerability in Medtronic Valleylab Exchange Client
CVE-2019-13543
Medtronic Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below use multiple sets of hard-coded credentials. If discovered, they can be used to read files on the device.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 5.8 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:N/A:N.
EPSS exploit prediction
EPSS: 0.020 (80.1th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 80th percentile — 80.1% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.020 · newest: 0.020 · change: 0.000
Affected products
- Medtronic Valleylab Exchange Client — versions 0
- Medtronic Valleylab Exchange Client
- Medtronic Valleylab Ft10 Energy Platform
- Medtronic Valleylab Ft10 Energy Platform Firmware
- Medtronic Valleylab Ft10 Energy Platform (Vlft10gen) — versions 0
- Medtronic Valleylab Fx8 Energy Platform
- Medtronic Valleylab Fx8 Energy Platform Firmware
- Medtronic Valleylab Fx8 Energy Platform (Vlfx8gen) — versions 0
Weakness classification (CWE)
References
- www.cisa.gov/news-events/ics-medical-advisories/icsma-19-311-02
- global.medtronic.com/xg-en/product-security/security-bulletins/valleylab-genera…
- af854a3a-2127-422b-91ae-364da2661108 (Third Party Advisory, US Government Resource)
Frequently asked questions
- What is CVE-2019-13543?
- CVE-2019-13543 is a medium-severity vulnerability in Medtronic Valleylab Exchange Client, classified under Use of Hard-coded Credentials. CVSS score: 5.8/10. Published 2019-11-08.
- How severe is CVE-2019-13543?
- Medium severity. CVSS v3 base score is 5.8 out of 10.